Trials / Completed
CompletedNCT05207644
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation: A Pilot Study to Evaluate the Safety and Acceptably of a User-friendly Regimen
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 30 mg letrozole followed by 800 mcg misoprostol | 30 mg letrozole on day 1 followed by 800 mcg misoprostol on day 3 |
Timeline
- Start date
- 2021-12-09
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
- First posted
- 2022-01-26
- Last updated
- 2022-06-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05207644. Inclusion in this directory is not an endorsement.